These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 37033960)

  • 1. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
    Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
    Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
    Li Z; Sun C; Qin Z
    Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
    Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
    Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution.
    Zhang F; Ma Y; Li D; Wei J; Chen K; Zhang E; Liu G; Chu X; Liu X; Liu W; Tian X; Yang Y
    J Hematol Oncol; 2024 Sep; 17(1):80. PubMed ID: 39223656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer.
    Zhou P; Du X; Jia W; Feng K; Zhang Y
    Signal Transduct Target Ther; 2024 Jun; 9(1):151. PubMed ID: 38910148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in the Tumor Microenvironment Mediated by Exosomal MicroRNAs.
    Chu X; Yang Y; Tian X
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer.
    Hussain Z; Bertran T; Finetti P; Lohmann E; Mamessier E; Bidaut G; Bertucci F; Rego M; Tomasini R
    Cell Commun Signal; 2024 Jan; 22(1):1. PubMed ID: 38167013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
    Peng Z; Ye M; Ding H; Feng Z; Hu K
    J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment.
    Nihashi Y; Song X; Yamamoto M; Setoyama D; Kida YS
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling.
    Raudenska M; Balvan J; Hanelova K; Bugajova M; Masarik M
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188940. PubMed ID: 37331641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal reprogramming: A target for tumor therapy.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem.
    Zhou X; Zhang P; Liu N; Zhang X; Lv H; Xu W; Huo M
    J Control Release; 2023 Sep; 361():161-177. PubMed ID: 37536546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Zhang T; Ren Y; Yang P; Wang J; Zhou H
    Cell Death Dis; 2022 Oct; 13(10):897. PubMed ID: 36284087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.